{"nctId":"NCT01375647","briefTitle":"Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh","startDateStruct":{"date":"2011-05"},"conditions":["Rotavirus Diarrhea","Vaccine Virus Shedding","Tropical Enteropathy"],"count":700,"armGroups":[{"label":"Rotarix + No IPV (inactivated polio vaccine)","type":"EXPERIMENTAL","interventionNames":["Biological: Rotarix"]},{"label":"Rotarix + IPV (inactivated polio vaccine)","type":"EXPERIMENTAL","interventionNames":["Biological: IPV (inactivated polio vaccine)","Biological: Rotarix"]},{"label":"No Rotarix + No IPV (inactivated polio vaccine)","type":"NO_INTERVENTION","interventionNames":[]},{"label":"No Rotarix + IPV (inactivated polio vaccine)","type":"EXPERIMENTAL","interventionNames":["Biological: IPV (inactivated polio vaccine)"]}],"interventions":[{"name":"IPV (inactivated polio vaccine)","otherNames":[]},{"name":"Rotarix","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Mother willing to sign informed consent form.\n2. Healthy infant aged 0 to 7 days old.\n3. No obvious congenital abnormalities or birth defects.\n4. No abnormal (frequency and consistency) stools since birth.\n5. Stable household with no plans to leave the area for the next one year.\n\nExclusion Criteria:\n\n1. Parents are not willing to have child vaccinated at the field clinic.\n2. Parents are not willing to have child's blood drawn.\n3. Parents are planning to enroll child into another clinical study during the time period of this trial.\n4. Mother not willing to have blood drawn and breast milk extracted.\n5. Parents not willing to have field research assistant in home two times per week.\n6. History of seizures or other apparent neurologic disorders.\n7. Infant received any vaccines before start of study, except Bacillus Calmette-Guerin (BCG).\n8. Infant has any sibling currently or previously enrolled in this study, including a twin.","healthyVolunteers":true,"sex":"ALL","maximumAge":"7 Days","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Presence of Fecal Shedding of Polio Vaccine Virus Determined by Culture (Polio Trial)","description":"Any Sabin type poliovirus in any fecal samples at days 0, 4, 11, 18 or 25 following week 52 dose","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"99","spread":null},{"groupId":"OG001","value":"109","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants With One or More Episodes of Rotavirus-associated Diarrhea (Rotavirus Trial)","description":"Diarrheal episode defined as presence of 3 or more abnormally loose stools in 24h period with \\>=72 hours separating episodes. Rotavirus antigen detected by ELISA in diarrheal stool.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67","spread":null},{"groupId":"OG001","value":"114","spread":null}]}]}]},{"type":"SECONDARY","title":"Duration of Fecal Shedding of Polio Vaccine Virus, Each Sabin Type (Polio Trial)","description":"Shedding index, calculated as duration days multiplied by mean log (shedding amount) for Sabin types 1, 2, and 3.\n\nOutcome is conditioned on infants with at least one detection by quantitative PCR (qPCR) at day 4,11,18, or 25. If shedding data point was missing it was assumed that the infant was not shedding at that time.\n\nLower shedding index is better outcome","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.9","spread":"4.8"},{"groupId":"OG001","value":"18.5","spread":"4.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.4","spread":"4.7"},{"groupId":"OG001","value":"19.6","spread":"3.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.7","spread":"4.5"},{"groupId":"OG001","value":"16.4","spread":"4.4"}]}]}]},{"type":"SECONDARY","title":"Community Fecal Shedding of Polio Vaccine Virus Just Prior to Oral Polio Vaccine Dose at 52 Weeks (Polio Trial)","description":"Only 8 infants were shedding at baseline so results are not presented for this outcome due to insufficient data","classes":[]},{"type":"SECONDARY","title":"Presence of Fecal Polio Virus Shedding Within the Three Sabin Strains (Polio Trial)","description":"Frequency (%) of infants excreting poliovirus at any of the 5 time points (day 0, 4,11,18, 25) post week 52 oral polio vaccine dose.\n\nPresence of poliovirus is determined by polymerase chain reaction (PCR)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67","spread":null},{"groupId":"OG001","value":"72","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22","spread":null},{"groupId":"OG001","value":"33","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"35","spread":null}]}]}]},{"type":"SECONDARY","title":"Serum Neutralizing Antibody Response (Polio Trial)","description":"Seropositive defined as antibodies present at â‰¥1:8 dilution, antibody titers \\<1:8 were seronegative.\n\nNon-seroconversions are those who did not seroconvert between week 18 (post oral polio vaccine dose 2) and week 40, adjusted for residual maternal antibody","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"79","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"62","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"110","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Number of Diarrheal Episodes (Rotavirus Trial)","description":"A diarrheal episode is defined as the presence of 3 or more abnormally loose stools in a 24 hour period with at least 72 diarrhea-free hours separating distinct episodes","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Duration of Rotavirus-associated Diarrheal Episodes (Rotavirus Trial)","description":"A diarrheal episode is defined as the presence of 3 or more abnormally loose stools in a 24 hour period with at least 72 diarrhea-free hours separating distinct episodes.\n\nRotavirus positive specimens were determined by ELISA Those with no rotavirus diarrheal episodes are counted as duration 0","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":16,"n":175},"commonTop":[]}}}